Bavarian Nordic is a vaccine-focused biotech company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases. In oncology, the company’s lead program is PROSTVAC®, a therapeutic vaccine candidate for advanced prostate cancer and the subject of an ongoing pivotal phase 3 trial. In infectious diseases, BVNKF’s lead program is IMVAMUNE®, a non-replicating smallpox vaccine. For further information, visit the company’s Web site at www.bavarian-nordic.com

EBD Group’s Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco for this important event.

Let us hear your thoughts below: